Cite
HARVARD Citation
Panés, J. et al. (n.d.). S810 Efficacy Outcomes by Symptom-Based Response Status After Induction: Week-48 Results from the GALAXI 1 Trial of Guselkumab in Crohn's Disease. American journal of gastroenterology. p. e580. [Online].